{
    "title": "Novo Nordisk launches 'strong' guidance, warns of supply constraints",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11699863/Novo-Nordisk-expects-13-19-sales-growth-2023.html",
    "date": "2023-02-01",
    "keywords": [
        "supply",
        "drug",
        "ozempic",
        "capacity",
        "share",
        "year",
        "growth",
        "production",
        "analyst",
        "novo",
        "nordisk",
        "demand",
        "wegovy",
        "disease",
        "franchise",
        "company",
        "comment",
        "wednesday",
        "obesity",
        "guidance",
        "dividend",
        "bln",
        "dkk",
        "ebit",
        "detail",
        "cfo",
        "reaction",
        "skydsgaard",
        "copenhagen",
        "developer",
        "blockbuster",
        "manufacturing",
        "officer",
        "munk",
        "knudsen",
        "market",
        "hormone",
        "midsingle",
        "digit",
        "percentage",
        "stock",
        "operating",
        "profit",
        "range",
        "bank",
        "henrik",
        "something",
        "laustsen",
        "response",
        "ingredient",
        "gmt",
        "high",
        "month",
        "programme",
        "reporting",
        "terje",
        "solsvik",
        "jan",
        "harvey"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}